AEON Biopharma, Inc.
Market Cap
20M
Short interest (May 15)
0.9%
Net Short (Jun 03 ): 0.0%
Borrow Fee
6.29%
↓ 13.8%
Available Shares
5M
↑ 1.9%
Price Chart
Company Overview
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.